Lauren Stival | Investor Relations |
Doug Fambrough | President and Chief Executive Officer |
Jack Green | Chief Financial Officer |
Ralf Rosskamp | Chief Medical Officer |
Mani Foroohar | SVB Leerink |
Jonathan Miller | Evercore |
Victor Rusu | Citi |
Steve Willey | Stifel |
Brandon Bingham | Cowen |
Ed Arce | H.C. Wainwright & Co. |
Fang-Ke Huang | SunTrust Robinson Humphrey |
Mayank Mamtani | B. Riley FBR |
Good afternoon, ladies and gentlemen and welcome to the Dicerna Pharmaceuticals’ Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer sessions and instructions will follow at that time.
As a reminder, this conference is being recorded at the company’s request.
I will now turn the call over to your host, Lauren Stival, representing Dicerna Pharmaceuticals.